Novavax gets US defense funding for its COVID-19 vaccine

Moderna’s (MRNA) Stock Will Surge 80% From Current Levels, Says Analyst

There’s no doubt about it, Moderna’s (MRNA) profile has increased dramatically since the pandemic’s onset.The biotech name has climbed 206% higher this year, as investors have piled in with the hope that its COVID-19 vaccine candidate, mRNA-1273, might be the one to solve the coronavirus conundrum.

Donald Trump went folksy, he loves helping Boris Johnson: HENRY DEEDES watches Global Vaccine Summit

HENRY DEEDES: Colourful outfits and a telegenic anchor who never let her Colgate smile drop once.

NIH chief worried vaccine "skepticism" might cause some to skip coronavirus vaccine

Vaccine skepticism may cause some people to skip the coronavirus vaccine, NIH director Francis Collins says.

Bill Gates warns anti-vaxxers could stop Covid-19 jab from working

Mr Gates, whose foundation has donated $250million to the hunt for a coronavirus vaccine, said scientists would want more than 80 per cent of people to have the Covid-19 jab if one is developed.

Vaccine summit exceeds target to raise almost £7bn

At the UK-hosted summit, Boris Johnson said up to eight millions lives will be saved by the funding.

AstraZeneca doubles capacity for potential Covid-19 vaccine to 2bn doses

Company will increase manufacturing capability after striking additional deal worth £595m Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has doubled the manufacturing capacity for its potential Covid-19 vaccine to 2bn doses after striking a number of deals that include two health organisations backed by Bill and Melinda Gates. Last month the pharmaceutical giant said it could manufacture 1bn doses of the vaccine that it is developing in partnership with with researchers at Oxford University.

Coronavirus vaccine: Boris Johnson calls for 'greater international collaboration'

The Prime Minister said up to eight million lives will be saved thanks to £7bn raised at the Gavi vaccine alliance summit

Bill Gates said it's hard to deny vaccine conspiracy theories involving him because they're 'so stupid'

Gates said that while it was "concerning" that some Americans believe the misinformation, that hasn't "held up" global funding for a COVID-19 vaccine.

Dr Fauci says US ‘could have a couple hundred million coronavirus vaccine doses’ by the end of the year

DOCTOR Anthony Fauci has expressed his hope that a mass-produced coronavirus vaccine will hit the US market by early next year.

Hackers targeted the UK's coronavirus vaccine research

On top of everything else, add cybersecurity threats to the list of things the UK's National Health Service (NHS) has had to contend with during the coronavirus pandemic.

Overlooked Covid-19 Vaccine Runners Up Defended by Wall Street

We can supply two billion potential vaccine doses, British firm says

British pharmaceutical company AstraZeneca says it now has capacity to deliver two billion doses of its potential coronavirus vaccine over the next two years.

Hackers targeting UK research labs amid vaccine race – GCHQ chief

China among hostile states believed to be trying to steal secrets during pandemic Coronavirus – latest updates See all our coronavirus coverage Britain’s intelligence agencies are working urgently to prevent hackers from hostile states, including China, trying to steal the secrets of a potential coronavirus vaccine, the head of GCHQ has said. Jeremy Fleming, said hackers – including those from hostile states – were targeting the UK’s health infrastructure and some of its world-leading research labs, often by using simple techniques.

FGM performed on girls unconscious 'for coronavirus vaccines'

father in Egypt forced his three unconscious daughters to undergo female genital mutilation after lying to them that a doctor was there to give them a coronavirus vaccine.

A coronavirus vaccine could require you to get two shots. Here's why.

There's a high likelihood a coronavirus vaccine will need two shots a month or so apart, with the possibility of a booster several years later.

Gilead Sciences (GILD) Leads Search for COVID-19 Vaccine

Diamond Hill Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below.

Trump praises Boris Johnson over vaccine fight as Transatlantic tensions simmer

The US President sent a video message to a global vaccine summit despite tensions over both the approach to coronavirus - and the President's attack on protesters demonstrating against George Floyd's death

Coronavirus news – live: Trump says pandemic 'mean and nasty' at global vaccine summit as UK quarantine plan questioned by scientific adviser

Follow the latest developments in the worldwide pandemic

World leaders must fund a Covid-19 vaccine plan before it's too late for millions | Gro Harlem Brundtland and Elizabeth Cousens

This week’s Global Vaccine Summit comes at a crucial point in history.

Inovio Suing Suppliers Over Covid-19 Vaccine Production

Inovio Pharmaceuticals (INO) has now initiated legal proceedings as an emergency action to compel the technology transfer required for the planned large-scale manufacture of its COVID-19 vaccine candidate.The company has an ambitious goal of producing one million doses of INO-4800 by the end of 2020, with its existing capacity and contract resources, for further clinical trials or emergency use.To fulfil this goal, INO has filed a complaint in Pennsylvania to compel VGXI, Inc.

Germany forges European virus vaccine alliance: Handelsblatt

Germany and three other European Union states are forging a new alliance aimed at securing access to coronavirus vaccines, once developed, and making sure they are distributed fairly around the world, business daily Handelsblatt reported.

5 Promising Covid-19 Vaccines Now Selected For Trump’s Operation Warp Speed

Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York Times reports.This comes as part of Operation Warp Speed (OWS), the administration’s national program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.Among its other objectives, Operation Warp Speed aims to have substantial quantities of a safe and effective vaccine available for Americans by January 2021.The five companies selected are as follows:Moderna’s (MRNA) mRNA1273 which is currently undergoing Phase 2 trials;A joint collaboration between AstraZeneca (AZN) and Oxford University on AZD1222 which is now in clinical trials at multiple UK sites;Johnson & Johnson (JNJ) which plans to start a Phase 1 clinical trial in September with an ultimate goal of supplying more than one billion doses of its coronavirus vaccine globally;Merck (MRK) which is trying to develop a vaccine using similar technology to its successful Ebola vaccine through a partnership with non-profit research organization IAVI, and;Pfizer (PFE) is working with German drugmaker BioNTech (BNTX) on clinical trials of BNT162, with plans to have a vaccine ready by the end of October, and produce “hundreds of millions” of doses in 2021.GlaxoSmithKline and Sanofi did not make the cut.On May 15 Operation Warp Speed revealed plans to select the most promising countermeasure candidates and provide coordinated government support to support their development.Large-scale randomized trials for the demonstration of safety and efficacy will proceed for three to five of the candidates, with as many as 150,000 people vaccinated if all five vaccine candidates reach the Phase 3 stage.Indeed, Congress has directed almost $10 billion to this effort through supplemental funding, including the CARES Act, with $3 billion directed for NIH research.“Vaccines are coming along really well,” President Trump told the Twittersphere on Tuesday. “

Fauci says he's optimistic about coronavirus vaccine protection, but concerned about how long that protection will last

In an interview with JAMA editor-in-chief Howard Bauchner, Dr Anthony Fauci questioned the 'durability' of these candidate vaccines.

Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics

The global economy is slowly emerging from lockdowns enacted to beat back the coronavirus.

UK chairs vaccine summit against backdrop of US-China battle

Virtual summit almost certain to reach global vaccine alliance target to combat disease over five years Boris Johnson will urge world leaders at a virtual summit to raise $7.4bn (£5.9bn) to distribute vaccines to combat infectious diseases in some of the poorest countries of the world over the next five years. Meeting the target, Johnson said ahead of Thursday’s summit, would show that humanity could finally come together on global health after months in which it has become contested diplomatic terrain, mainly between the US and China.

Stalled vaccine programmes 'put children's lives at risk'

Disruption to immunisation campaigns caused by Covid-19 could lead to many preventable deaths.

Vaccine group plans advance market agreement for COVID-19 vaccines

The GAVI vaccines alliance is to launch an Advance Market Commitment (AMC) for future COVID-19 vaccines which it says will help secure access to the new shots for poorer countries.

Trump administration selects five coronavirus vaccine candidates as finalists: NYT

The other two companies are Johnson & Johnson and Merck & Co Inc, according to the paper. The se

Animal medicine might play a crucial role in developing the sought-after coronavirus vaccine

Coronavirus News: Live Updates

By winnowing the field, the White House hopes to speed the process of vaccine development.

Moderna’s New Vaccine Business Could Be Bigger Than COVID, Says 5-Star Analyst

Coronavirus is a monster, a pandemic, a threat to humanity on a global scale.Do I overstate the case? Perhaps, but after nearly 375,000 deaths globally, and 6.2 million infections -- meaning there will be more deaths to come -- I don't think I overstate the case by much.Coronavirus has already tipped the United States into a recession, and most of the rest of the world as well.

Vaccine group plans advance market agreement for COVID-19 vaccines

US should have a 'couple hundred million' doses of a Covid-19 vaccine by the start of 2021, Fauci says

The United States should have 100 million doses of one candidate coronavirus vaccine by the end of the year, Dr Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases and a member of the White House Coronavirus Task Force, said Tuesday.

How would a global effort for a vaccine work?

Sir Jeremy Farrar is director of the Wellcome Trust and was previously director of the Oxford University Clinical Research Unit in Vietnam for 18 years.

Putin declines British invitation to take part in coronavirus summit: Kremlin

Russian President Vladimir Putin does not plan to take part in an online summit on a possible coronavirus vaccine being organised by the British government this week, Kremlin spokesman Dmitry Peskov said on Wednesday.

I volunteered for the coronavirus vaccine trial - here's what happened

Human trials are under way of a potential vaccine for COVID-19 being developed by scientists at the University of Oxford.

Coronavirus is the day of reckoning for the anti-vaccine movement

Stoked by poor communication and disinformation, fears of a coronavirus vaccine are brewing online.

Fauci is 'optimistic' Moderna's coronavirus vaccine will work

America's top infectious disease expert, Dr Anthony Fauci, said he is 'cautiously optimistic' that one of several coronavirus vaccines being developed in the US will be ready in a 'reasonable period of time.'

Reasonable to expect some coronavirus vaccine by year-end, Pentagon researcher says

A senior US Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine could be available to part of the US population by the end of the year.

Reasonable to expect some coronavirus vaccine by year-end, Pentagon researcher says

A senior US Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine could be available to part of the US population by the end of the year.

Drugs to treat Covid-19 are 'essential' because a vaccine will take YEARS to roll out

Dr Nick Cammack, head of the Wellcome Trust's Covid-19 Therapeutic Accelerator project into promising therapies, urged caution to those pinning their hopes on a jab being mass-produced this year.

Exclusive: Lonza sets new goal to make Moderna COVID-19 vaccine ingredients

Lonza aims to speed completion of two commercial production lines for Moderna Inc's trial COVID-19 vaccine so manufacturing could start four to six weeks earlier than planned if the project is successful, the Swiss drugmaker's chairman said on Tuesday.

China warning: Alarm bells over global conflict - MP issues alert over sick plot

CHINA will use a COVID-19 vaccine to flex its muscles and boost its global influence, escalating the risk of "global conflict", MP Tobias Ellwood has warned.

China's fearsome plot to 'leverage' COVID-19 vaccine to further world domination

CHINA may threaten the world by leveraging a coronavirus vaccine rollout to further its political dominance on western countries, warned Tory MP Tobias Ellwood.

George Clooney: Racism Is Our Pandemic And In 400 Years We’ve Yet To Find A Vaccine

In a new column responding to the death of George Floyd, the actor slammed leaders who "stoke hatred and violence."

Moderna launches second phase trial for its coronavirus vaccine

On Friday, Moderna dosed the first participants in a trial to test whether its coronavirus shot can block infection, but experts have questioned the medical validity of its first trial as well as its financial gains.

Will a Covid-19 vaccine signal an end to the anti-vaccine movement?

Peter J. Hotez and John Hewko write that the costs are too great to allow for irrational fear of vaccines to outweigh the real consequences of catching a disease such as Covid-19, which is claiming lives, and causing unprecedented changes in society.

Eli Lilly Shares Jump After Healthcare Group Doses First Patients in COVID-19 Vaccine Trial

Eli Lilly said its early stage vaccine trial is "the world's first study of a potential antibody treatment designed to fight COVID-19"

US awards new $628 million contract to boost output of potential COVID-19 vaccine

As drugmakers race to develop vaccines, tests and therapies for COVID-19, the United States is looking to secure manufacturing capacity under its "Operation Warp Speed" program announced in May to accelerate vaccine development.

Moderna's coronavirus vaccine announcement set off a frenzy on Wall Street. Now some are calling for an investigation

Moderna set off a frenzy on Wall Street earlier this month when it announced positive, preliminary results from its coronavirus vaccine trial.

Spain on target to develop coronavirus vaccination ‘sooner than expected’

Sanchez highlighted that one of the greatest resources Spain has to combat COVID-19 is its scientific and research community.

University of Oxford coronavirus vaccine: everything we know so far

Coronavirus vaccine hunt could be harmed by falling infection rate warns expert

AS THE COUNTRY and the world awaits a coronavirus vaccine, a race against time to conduct human trials has emerged due to the decline of Covid-19 infections in the UK.

Pope presides over virus prayer in hint normalcy returning

Pope Francis prayed Saturday for an end to the coronavirus pandemic and the development of a vaccine as he presided over an outdoor gathering that signaled a semblance of normalcy returning to the Vatican after a coronavirus lockdown lasting more than two months.

Coronavirus, Racism and Injustice: No One Is Coming to Save Us

Eventually doctors will find a coronavirus vaccine, but black people will continue to wait for a cure for racism.

Vaccine and coronavirus skeptics packed into a hotel for a conference over Memorial Day weekend, defying guidelines

200 alternative medicine practitioners and followers attended a conference in a North Carolina hotel over Memorial Day weekend, defying guidelines.

The anti-vax movement is using growing hesitation around the coronavirus vaccine to attract more people

Surveys suggest Americans are increasingly unsure if they'd get a coronavirus vaccine.

Football will be 'very different' until coronavirus vaccine found, Fifa warn

The governing body has released a risk assessment tool to help its 211 member associations and six continental confederations facilitate a safe return to football

Chinese vaccine could be ready by year-end, government body says

A Chinese-made coronavirus vaccine could be ready for market as early as the end of this year, China's State-owned Assets Supervision and Administration Commission (SASAC) said in a social media post.

US to Quit WHO; Vaccine Progress in China: Virus Update

Coronavirus: Bill Gates ‘microchip’ conspiracy theory and other vaccine claims fact-checked

Fact-checking vaccine claims - including ones about the ex-Microsoft boss and a dubious cow-dung trial.

Vaccine Politics Take Center Stage In Competitive Democratic Primaries

In Vermont and New York, veteran lawmakers are on the defensive about past vaccine skepticism.

Fifa: Football 'quite different' until vaccine developed

The football environment will be "quite different" until a vaccine for coronavirus is developed, Fifa tells its member federations.

FIFA: Football different until COVID-19 vaccine found

FIFA has warned that football will be "very different" until a COVID-19 vaccine is found.

99% chance that coronavirus vaccine will work, says Chinese firm

Chinese scientists working on a COVID-19 vaccine have told Sky News they are "99%" sure it will be effective.

Another threat looming in the fight against coronavirus: anti-vaxxers

Anti-vaxxers have taken aim at the very thing epidemiologists say can defeat the virus – an as yet undeveloped vaccine Coronavirus – live US updates Live global updates A coronavirus vaccine may be a long way away, but there is already a threat on the horizon: anti-vaxxers. Once a fringe presence in America, vaccine opponents have become better organized in recent years, a development that has contributed to the worst US measles outbreak in a generation in 2019.

Pharma chiefs see coronavirus vaccine by year-end, but challenges 'daunting'

Pharmaceutical company executives said Thursday that one or several COVID-19 vaccines could begin rolling out before 2021, but warned the challenges would be "daunting" as it was estimated that 15 billion doses would be needed to halt the pandemic.

Coronavirus breakthrough as ‘several’ vaccines READY by the end of the year

CORONAVIRUS VACCINE hopes have seen a major boost as AstraZeneca claims ‘several' will be ready by the end of the year.

Defense secretary says coronavirus vaccine will be available within months, but experts skeptical

Pentagon leaders expressed strong confidence Thursday that a coronavirus vaccine will be available by January, and possibly as early as this fall — claims that were met with skepticism by scientific experts.

How Novavax is pulling out all the stops to produce a coronavirus vaccine by next year

If all goes according to plan, Novavax anticipates being able to produce 100 million doses in 2020, mostly for frontline workers, and 1 billion doses by 2021.

AstraZeneca says it may consider exposing vaccine trial participants to virus

Companies and research institutions are currently working on more than 100 vaccines, about 10 of which are being tested on humans, in a bid to stop the respiratory illness that at present has no treatment and has killed about 350,000 people.

ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic'

As the fallout from the coronavirus pandemic continues, the search for a vaccine is not slowing down.

Novartis inks deal to make Mass General Brigham's COVID-19 vaccine candidate

Novartis's gene therapy unit AveXis has signed a manufacturing deal to help produce a novel genetic COVID-19 vaccine candidate being developed by US researchers in Massachusetts, a spokeswoman for the Swiss drugmaker confirmed on Thursday.

AstraZeneca partners with Oxford Biomedica to expand COVID-19 vaccine manufacturing capacity

The experimental shot is also being produced by the Serum Institute of India, the world's largest manufacturer of vaccines by volume, and AstraZeneca is in talks with several governments and global partners to increase production.

Exclusive: GSK says science does not link pandemic H1N1 flu vaccine to sleep disorder

British drugmaker GSK said on Thursday that its previous flu pandemic vaccine, which used some of the same ingredients as COVID-19 vaccines currently under development, was not linked to a rise in cases of the sleep disorder narcolepsy.

Novavax Seeks To Make 1 Billion Covid-19 Vaccine Doses; Top Analyst Ramps Up PT To $61

Novavax (NVAX) on Wednesday announced the acquisition of Praha Vaccines to help the late-stage biotech company produce over 1 billion doses of its experimental Covid-19 vaccine candidate starting in 2021.The US company will buy the manufacturing plant for about $167 million in an all cash transaction.

Potential guidelines for ethically infecting vaccine volunteers with coronavirus

A University of Warwick researcher suggests this may significantly speed up the process of vaccine development and potentially save many liv

Coronavirus vaccine test patient ‘fainted and was sicker than he’d ever been’ after getting Moderna injection

A CORONAVIRUS vaccine test patient  said he fainted and felt sicker than ever after getting the Moderna injection, reports say.  Ian Haydon, 29, from Seattle was one of four volunteers who reacted badly during the COVID-19 clinical trials run by Moderna, who touted the positive early findings.

Moderna rally loses steam over COVID-19 vaccine worries

Shares of biotechs racing to make coronavirus vaccines, including Moderna Inc , fell about 10% on Wednesday, as investor concerns grew about the prospects of the experimental products that are still in early stages of development.

Novavax aims to make 1 billion COVID-19 vaccine doses after buying plant

The US company said on Wednesday it would buy Czech Republic-based Praha Vaccines, a unit of India's Cyrus Poonawalla Group, which also owns Serum Institute, for $167 million in cash.

Novavax aims to make one billion COVID-19 vaccine doses after buying plant

'Unstoppable': African swine fever deaths to eclipse record 2019 toll

With world’s attention on Covid-19, warnings that lack of measures to contain pandemic could lead to culling of record number of pigs The African swine fever (ASF) pandemic will be even worse this year than in 2019, say experts, warning that the spread of the highly contagious virus, which is fatal to pigs, is unrelenting. With world attention on the human viral pandemic of Covid-19, concern is growing that countries are not focusing enough on halting the spread of ASF through better biosecurity practices, cooperation on intensive vaccine development, or transparency regarding outbreaks.

Andrea Bocelli secretly battled coronavirus and is donating blood to vaccine research

The 61-year-old Italian tenor tested positive for the virus in March and is donating his blood to help researchers.

THIS country refuses to reopen schools without COVID-19 vaccine

PHILIPPINES' President Rodrigo Duterte has told the nation that he will not allow schools to reopen without a vaccine for coronavirus.

There's one epidemic we may never find a vaccine for: fear of black men in public spaces

The Central Park dog dispute, the Minneapolis police fatal arrest and the Ahmaud Arbery shooting are fresh reminders that black men have long been a bogeyman in White America's collective psyche.

Andrea Bocelli secretly battled COVID-19 in MARCH and is donating his blood to help with vaccine

Andrea Bocelli has revealed he and members of his family are COVID-19 survivors.

Dow Jones Futures Hit Session Highs; Tech Giants Alphabet, Apple Stage Breakouts In Coronavirus Vaccine Stock Market Rally

The Dow Jones futures were higher late Tuesday following the coronavirus stock market rally.

Coronavirus man-made or 'complete fluke' says vaccine expert

Adelaide Professor Nikolai Petrovsky said the virus was so 'perfectly adapted' to infect humans that the possibility it was made in a Chinese lab can't be ignored and needed to be urgently investigated.

Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race

Novavax, Inc. (NASDAQ: NVAX), which last month landed CEPI funding for its coronavirus vaccine program, announced Tuesday the initiation of human studies of its vaccine candidate, NVX-CoV2373.The Novavax Analysts Cantor Fitzgerald analyst Charles Duncan maintained an Overweight rating on Novavax with a $45 price target.

Coronavirus latest: Tuesday, May 26

On Tuesday, Novavax announced that it was moving forward with its clinical trials for its coronavirus vaccine.

Coronavirus US: Vaccine trial participant fainted after injection

Ian Haydon, 29, from Seattle, Washington, developed a 103.2F fever and fainted at home after receiving his second dose of Moderna Therapueticss' coronavirus vaccine candidate

S&P 500 rises on economic recovery and vaccine hopes, pulls back from highs

US stocks closed higher on Tuesday on optimism about the development of coronavirus vaccines and a revival of business activity, but the S&P 500 failed to hold above the key psychological level of 3,000 points.

CANADA FX DEBT-C$ surges to 2-month high as economic reopening pressures bears

World shares forged ahead and commodity markets drove higher as investors disregarded Sino-US tensions to focus on the easing of lockdowns and a potential coronavirus vaccine.

Column: Moderna execs sold $29 million in stock after its early vaccine announcement

Within 48 hours of Moderna's vaccine announcement, its execs sold $29 million in shares.

Travel shares soar on FTSE 100 amid hopes holiday curbs will ease

British Airways owner IAG and easyJet among those to rise as retail stocks also make gains Global financial markets have rallied on rising hopes for a coronavirus vaccine and a smooth recovery for the world economy as governments gradually ease lockdown restrictions. In the UK the FTSE 100 rose by 1.2% or 74 points as countries around the world begin the lengthy task of reopening their economies as the health emergency shows signs of gradually easing.

S&P 500 clears 3,000 barrier on economic recovery and vaccine hopes

US stocks jumped on Tuesday, propelling the S&P 500 past the key psychological level of 3,000 points as optimism about developing coronavirus vaccines and the revival of business activity helped investors overlook simmering China-US tensions.

S&P 500 clears 3,000 barrier on hopes of recovery, vaccine

ṄUS stocks jumped and the S&P 500 crossed 3,000 points on Tuesday as optimism about a potential coronavirus vaccine and a revival in business activity helped investors overlook simmering Sino-US tensions.

Novavax begins phase one of coronavirus vaccine trial after $388M Gates-backed group funding

Novavax has begun phase one of its clinical trail for a coronavirus vaccine candidate.

Novavax expects COVID-19 vaccine trial results in July

Biotech firm Novavax has entered its coronavirus vaccine in a Phase 1 clinical trial in Australia — the first in the Southern Hemisphere.